Recent Patents on AntiCancer Drug Discovery
Home
FOR AUTHORS
ARTICLES
SUBSCRIBERS & CORPORATES
FOR REVIEWERS
CONTENTS & ABSTRACTS
CONTACT US
Tuesday, May 9, 2017
Open Access Article: Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens
3:28 AM
No comments
Open Access Article: Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens
Email This
BlogThis!
Share to Twitter
Share to Facebook
Newer Post
Older Post
Home
0 comments:
Post a Comment
Social Profiles
Popular
Tags
Blog Archives
Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Author(s): Zsuzsanna SubaPages 154-167 (14) Abstract: Literary data suggest apparently ambiguous interaction between menopausal status...
Most Accessed Article:Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
Most Accessed Article:Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
Open Access Article: Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens
Open Access Article: Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Ant...
Most Accessed Article: Mapping the Technological Knowledge Landscape: The Case of Epigenetics
Most Accessed Article: Mapping the Technological Knowledge Landscape: The Case of Epigenetics
Highlighted Article: Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conse...
Most Citied Article : HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Most Citied Article : HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Issue Publish Recent Patents on Anti-Cancer Drug Discovery
New Issue Publish Recent Patents on Anti Cancer Dru Discovery Vol. 11 Issue 4.
Open Access Article: Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Open Access Article: Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Open Access Article: "Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response "
Open Access Article: "Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response "
Most Accessed Article: Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy
Most Accessed Article: Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy
Blog Archive
►
2018
(1)
►
January
(1)
▼
2017
(34)
►
November
(1)
►
October
(3)
►
September
(2)
►
August
(3)
►
July
(4)
►
June
(3)
▼
May
(3)
Free Trial Request
Most Accessed Article: HSP90 Inhibitors:Current De...
Open Access Article: Activating Mutations of ESR1,...
►
April
(3)
►
March
(4)
►
February
(2)
►
January
(6)
►
2016
(22)
►
December
(5)
►
November
(5)
►
October
(7)
►
August
(1)
►
June
(4)
Blogger templates
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion
0 comments:
Post a Comment